Class information for:
Level 1: ALZHEIMERS DISEASE//BAPINEUZUMAB//AMYLOID BETA

Basic class information
Class id #P Avg. number of
references		 Database coverage
of references
3379 1997 59.5 92%


Bar chart of Publication_year

Last years might be incomplete

Hierarchy of classes
The table includes all classes above and classes immediately below the current class.


Cluster id Level Cluster label #P
11 4 NEUROSCIENCES//CLINICAL NEUROLOGY//NEUROL 1112395
49 3       ALZHEIMERS DISEASE//AMYOTROPHIC LATERAL SCLEROSIS//DEMENTIA 92146
35 2             ALZHEIMERS DISEASE//AMYLOID PRECURSOR PROTEIN//TAU 32531
3379 1                   ALZHEIMERS DISEASE//BAPINEUZUMAB//AMYLOID BETA 1997

Terms with highest relevance score


rank Term termType Chi square Shr. of publ. in
class containing
term		 Class's shr. of
term's tot. occurrences		 #P with term
in class
1 ALZHEIMERS DISEASE authKW 360672 50% 2% 1004
2 BAPINEUZUMAB authKW 225157 1% 82% 18
3 AMYLOID BETA authKW 211685 10% 7% 203
4 SOLANEZUMAB authKW 192099 1% 74% 17
5 AMYLOID authKW 111060 10% 4% 192
6 GANTENERUMAB authKW 108719 0% 89% 8
7 A BETA IMMUNIZATION authKW 107022 0% 100% 7
8 AN1792 authKW 107022 0% 100% 7
9 TG2576 authKW 106033 1% 25% 28
10 APP TRANSGENIC MICE authKW 99872 1% 47% 14

Web of Science journal categories


Rank Term Chi square Shr. of publ. in
class containing
term		 Class's shr. of
term's tot. occurrences		 #P with term
in class
1 Neurosciences 22886 61% 0% 1227
2 Geriatrics & Gerontology 4028 8% 0% 157
3 Clinical Neurology 2260 16% 0% 316
4 Immunology 751 11% 0% 219
5 Medicine, Research & Experimental 609 8% 0% 152
6 Behavioral Sciences 604 4% 0% 87
7 Pathology 517 5% 0% 104
8 Pharmacology & Pharmacy 277 9% 0% 189
9 Biochemistry & Molecular Biology 215 13% 0% 264
10 Cell Biology 80 5% 0% 108

Address terms


Rank Term Chi square Shr. of publ. in
class containing
term		 Class's shr. of
term's tot. occurrences		 #P with
term in
class
1 ALZHEIMERS 57752 2% 10% 37
2 MEMORY IMPAIRMENTS NEUROL DISORDERS 49405 1% 12% 26
3 IMMUNE SYST NEUROINFLAMMAT NEURODEGENERAT D 45867 0% 100% 3
4 RASHID DEV NEUROBIOL 44030 1% 26% 11
5 PUBL HLTH CARING SCI MOL GERIATR 42332 0% 46% 6
6 CELLULAR NEUROL 38393 1% 15% 17
7 BRAIN AGING DEMENTIA 36162 1% 8% 28
8 LONGTIME MOL BIOL GENET 34398 0% 75% 3
9 SILVER CHILD DEV 33960 1% 22% 10
10 TRANSLAT NEURODEGENERAT DIS 33214 1% 12% 18

Journals


Rank Term Chi square Shr. of publ. in
class containing
term		 Class's shr. of
term's tot. occurrences		 #P with
term in
class
1 JOURNAL OF ALZHEIMERS DISEASE 29158 5% 2% 93
2 NEUROBIOLOGY OF AGING 28110 5% 2% 103
3 CURRENT ALZHEIMER RESEARCH 22078 2% 4% 37
4 ALZHEIMERS RESEARCH & THERAPY 19170 1% 6% 21
5 JOURNAL OF NEUROINFLAMMATION 13832 2% 2% 39
6 NEUROBIOLOGY OF DISEASE 12566 3% 2% 55
7 NEURODEGENERATIVE DISEASES 7985 1% 3% 19
8 CNS & NEUROLOGICAL DISORDERS-DRUG TARGETS 5575 1% 2% 18
9 MOLECULAR NEURODEGENERATION 5343 1% 3% 14
10 JOURNAL OF NEUROIMMUNE PHARMACOLOGY 4829 1% 2% 14

Author Key Words


Rank Term Chi square Shr. of publ. in
class containing
term		 Class's shr. of
term's tot. occurrences		 #P with term
in class		 LCSH search Wikipedia search
1 ALZHEIMERS DISEASE 360672 50% 2% 1004 Search ALZHEIMERS+DISEASE Search ALZHEIMERS+DISEASE
2 BAPINEUZUMAB 225157 1% 82% 18 Search BAPINEUZUMAB Search BAPINEUZUMAB
3 AMYLOID BETA 211685 10% 7% 203 Search AMYLOID+BETA Search AMYLOID+BETA
4 SOLANEZUMAB 192099 1% 74% 17 Search SOLANEZUMAB Search SOLANEZUMAB
5 AMYLOID 111060 10% 4% 192 Search AMYLOID Search AMYLOID
6 GANTENERUMAB 108719 0% 89% 8 Search GANTENERUMAB Search GANTENERUMAB
7 A BETA IMMUNIZATION 107022 0% 100% 7 Search A+BETA+IMMUNIZATION Search A+BETA+IMMUNIZATION
8 AN1792 107022 0% 100% 7 Search AN1792 Search AN1792
9 TG2576 106033 1% 25% 28 Search TG2576 Search TG2576
10 APP TRANSGENIC MICE 99872 1% 47% 14 Search APP+TRANSGENIC+MICE Search APP+TRANSGENIC+MICE

Core articles
The table includes core articles in the class. The following variables is taken into account for the relevance score of an article in a cluster c:
(1) Number of references referring to publications in the class.
(2) Share of total number of active references referring to publications in the class.
(3) Age of the article. New articles get higher score than old articles.
(4) Citation rate, normalized to year.


Rank Reference # ref. in
cl.		 Shr. of ref. in
cl.		 Citations
1 FU, HJ , LIU, B , FROST, JL , LEMERE, CA , (2010) AMYLOID-BETA IMMUNOTHERAPY FOR ALZHEIMER'S DISEASE.CNS & NEUROLOGICAL DISORDERS-DRUG TARGETS. VOL. 9. ISSUE 2. P. 197-206 94 82% 43
2 LEMERE, CA , MASLIAH, E , (2010) CAN ALZHEIMER DISEASE BE PREVENTED BY AMYLOID-BETA IMMUNOTHERAPY?.NATURE REVIEWS NEUROLOGY. VOL. 6. ISSUE 2. P. 108 -119 76 66% 178
3 LALONDE, R , FUKUCHI, K , STRAZIELLE, C , (2012) APP TRANSGENIC MICE FOR MODELLING BEHAVIOURAL AND PSYCHOLOGICAL SYMPTOMS OF DEMENTIA (BPSD).NEUROSCIENCE AND BIOBEHAVIORAL REVIEWS. VOL. 36. ISSUE 5. P. 1357 -1375 134 45% 20
4 PANZA, F , LOGROSCINO, G , IMBIMBO, BP , SOLFRIZZI, V , (2014) IS THERE STILL ANY HOPE FOR AMYLOID-BASED IMMUNOTHERAPY FOR ALZHEIMER'S DISEASE?.CURRENT OPINION IN PSYCHIATRY. VOL. 27. ISSUE 2. P. 128-137 61 71% 34
5 WISNIEWSKI, T , GONI, F , (2015) IMMUNOTHERAPEUTIC APPROACHES FOR ALZHEIMER'S DISEASE.NEURON. VOL. 85. ISSUE 6. P. 1162 -1176 63 48% 54
6 WANG, YJ , ZHOU, HD , ZHOU, XF , (2010) MODIFIED IMMUNOTHERAPIES AGAINST ALZHEIMER'S DISEASE: TOWARD SAFER AND EFFECTIVE AMYLOID-BETA CLEARANCE.JOURNAL OF ALZHEIMERS DISEASE. VOL. 21. ISSUE 4. P. 1065-1075 75 77% 12
7 GOLDE, TE , DAS, P , LEVITES, Y , (2009) QUANTITATIVE AND MECHANISTIC STUDIES OF A BETA IMMUNOTHERAPY.CNS & NEUROLOGICAL DISORDERS-DRUG TARGETS. VOL. 8. ISSUE 1. P. 31-49 74 77% 23
8 PANZA, F , FRISARDI, V , SOLFRIZZI, V , IMBIMBO, BP , LOGROSCINO, G , SANTAMATO, A , GRECO, A , SERIPA, D , PILOTTO, A , (2012) IMMUNOTHERAPY FOR ALZHEIMER'S DISEASE: FROM ANTI-BETA-AMYLOID TO TAU-BASED IMMUNIZATION STRATEGIES.IMMUNOTHERAPY. VOL. 4. ISSUE 2. P. 213-238 91 48% 58
9 VON BERNHARDI, R , (2010) IMMUNOTHERAPY IN ALZHEIMER'S DISEASE: WHERE DO WE STAND? WHERE SHOULD WE GO?.JOURNAL OF ALZHEIMERS DISEASE. VOL. 19. ISSUE 2. P. 405-421 96 55% 11
10 PANZA, F , SOLFRIZZI, V , IMBIMBO, BP , TORTELLI, R , SANTAMATO, A , LOGROSCINO, G , (2014) AMYLOID-BASED IMMUNOTHERAPY FOR ALZHEIMER'S DISEASE IN THE TIME OF PREVENTION TRIALS: THE WAY FORWARD.EXPERT REVIEW OF CLINICAL IMMUNOLOGY. VOL. 10. ISSUE 3. P. 405 -419 69 55% 34

Classes with closest relation at Level 1


Rank Class id link
1 20963 GLUTAMINYL CYCLASE//INTRANEURONAL A BETA//PYROGLUTAMATE
2 22367 CELLULAR NEUROSCI NEURODEGENERAT REPAIR PROGRAM//AMYLOID BETA PEPTIDE 25 35//AMYLOID BETA PROTEIN OLIGOMERS
3 478 AMYLOID BETA PEPTIDE//AMYLOID BETA PROTEIN//ALZHEIMERS DISEASE
4 13268 INTERLEUKIN 6//ALZHEIMERS DISEASE//IL 6 MESSENGER RNA
5 14501 BETA AMYLOID PLAQUES//CHRYSAMINE G//WUHAN NEUROSCI NEUROENGN
6 9059 BACE1//BETA SECRETASE//BACE1 INHIBITOR
7 10681 CYCLOOXYGENASE//NEUROINFLAMMAT S//BUTAPROST
8 1390 PRESENILIN//GAMMA SECRETASE//PRESENILIN 1
9 14129 NEUROFIBRILLARY TANGLES//SENILE PLAQUES//BETA A4 DEPOSITS
10 31950 CLINICAL DEMENTIA//MENTAL IMPAIRMENTS NEUROL DISORDERS MIND//PHARMACONEUROIMMUNOL PROGRAM

Go to start page